Jamie Zimmerman

#NeoGenomics just announced the launch of NEO | AML Express™ panel. With a class-leading turnaround time of 3-4 days, Neo | AML Express delivers comprehensive NGS-based assessment with timely diagnostic, prognostic and predictive biomarker information. 𝐖𝐡𝐞𝐧 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬, 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐰𝐡𝐨 𝐲𝐨𝐮 𝐚𝐬𝐤. Make the right decision at the right time for your acute myeloid leukemia patients with a personalized solution, delivering patient-specific insights to help guide precise treatment strategies. #AML #AcuteMyeloidLeukemia #NGS #CancerTesting #Oncology https://lnkd.in/e7dK9aRe

67

2 Comments

What an interesting read on the shift from traditional patient recruitment methods in rare disease! Learn more about how to optimize patient-driven site engagement in my team member’s blog: https://bit.ly/4eHoBn4

3

Had a fantastic time earlier this month, participating in a panel discussion on Forecasting, IRA, and the use of AI at the New Product Planning Summit in Boston, where biopharma pros gathered to tackle key industry challenges. Key takeaways: 1️⃣ Forecasting is more than just crunching numbers. It’s about getting everyone on the same page with consistent assumptions, transparency, and a solid process, especially when managing many stakeholders and assets. 2️⃣ The impact of IRAs is still unfolding; NPP and indication-extension long-range forecasts should scenario plant revenue impact from IRA mandates. 3️⃣ AI might be moving fast but the proof points are unclear, more so in Forecasts – regression and Excel are still king. 4️⃣ The traditional LCM model is evolving, and early collaboration between New Product Planning and Development is paramount. A huge shoutout to my fellow panelists Aaron Furtado, Ashley Robinson, Deepak Wadhwa, and Erik Holzinger for bringing their expertise and enriching this discussion. It was a pleasure to exchange ideas and learn from everyone’s experiences. I'm looking forward to seeing how these trends evolve and keep shaping the future of forecasting! Special thanks to Heath Clendenning and Fierce Pharma for organizing the discussion and Erik Holzinger for moderating it.  Read Erik's post with his reflections here: https://lnkd.in/gYtEtP72 #forecasting #AI #IRA #demandplanning #analytics #NPP

112

Looking forward to attending #ASH2024 this year. Let's connect and I can share with you how TD2 can support your next trial. 🔗https://hubs.li/Q02YXgqv0 #HematologyOncology #ClinicalTrials #OncologyCRO #BloodCancerResearch #DrugDevelopment #PrecisionOncology #ClinicalTrialSolutions

1

Curious what solutions my network recommends to aggregate calendars from multiple accounts to have a consolidated view but keeping it all private and also having a feature where you can share a scheduling link that only shows pre-set open times for scheduling on demand. Ideally looking for free or low cost options.

1

3 Comments

With the amount of data collected daily in healthcare provision, and the complex decision making throughout the system, AI holds great promise in this industry. And yet, disruption has been slow and steady, rather than transformational, over the last decade. A great interview well worth the full watch examines some of the challenges, and paths forward to AI in the US healthcare ecosystem. Gaining he “trust” of practitioners is particularly salient, with the recommendation to build models with engagement and endorsement of physicians, makes a ton of practical sense.

54

3 Comments

Did you know that Worldwide partners with over 115 rare disease organizations around the globe to help leverage shared expertise so we can improve patient outcomes and accelerate breakthroughs in drug development? Learn more about these partnerships and how these organizations are helping make an impact on rare disease clinical research in our blog: https://bit.ly/3Z4Junj

5

Thoughts on this? >> AvenCell gets $112M to build switchable CAR-T therapies for ‘the last frontier’ of blood cancers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #healthcare #pharma

12

1 Comment

Thoughts on this? >> Medable Partners with Google Cloud to Accelerate Clinical Trials >> Comment below! >>> lqventures.com #mhealth #industry40 #AI #healthtech #IoT

1

Comprehensive McKinsey & Company report on #Generative #AI in #healthcare: Adoption trends and what’s next. As an ever-evolving field, the hot topic of AI has huge potential applications in healthcare. It's interesting to discuss how fast and how far it will go. An insightful read. #healthcaretechnology #trends2024

6

Looking to empower your oncology trials with specialized CRO training? Our latest white paper dives into the critical role CRAs play in managing advanced oncology trials and how specialized training can help set up your trial for success. Download your copy today! https://bit.ly/48k1RHG

5